PCI Outcomes in Patients With a History of Cerebrovascular Disease
that patients with a history of stroke are at an increased risk of adverse events, 3, 4 along with the relatively high prevalence of patients with a history of TIA or stroke undergoing PCI, it is important to understand whether such patients are at an increased risk of in-hospital and postdischarge outcomes after PCI in real-world practice. Therefore, we sought to examine this relationship using a large, contemporary, clinical registry of all PCIs performed at nonfederal hospitals in the state of Michigan.
Methods
We performed a retrospective analysis using data collected by the Blue Cross Blue Shield of Michigan Cardiovascular Consortium. This is a prospective, multicenter, statewide registry of patients who underwent PCI at all nonfederal hospitals in Michigan. A more detailed description of the registry has been described previously. 10, 11 We evaluated consecutive patients who underwent PCI between January 1, 2013, and March 31, 2016, at 47 PCI-capable hospitals in Michigan. Among this group, we stratified patients by whether they had a history of TIA or stroke. TIA was defined as a loss of neurological function that was abrupt in onset but with complete return of function within 24 hours. Stroke was defined as a loss of neurological function with residual symptoms at least 72 hours after onset. A history of TIA or stroke was determined by review of the medical record by each institution's trained registry abstractors. Further details on the abstraction and auditing process of registry records have been described previously. 11 The University of Michigan Institutional Review Board approved the study and determined that it met the definition of research not requiring informed consent. The analytic and statistical methods will be made available through M.S. (mcseth@med.umich.edu) to other researchers for purposes of reproducing the results or replicating the procedure. However, the study data set cannot be shared because of our data use agreements.
Primary In-Hospital Outcomes
We compared post-PCI in-hospital outcomes among patients with and without a history of TIA or stroke. All in-hospital outcomes were assessed during the index hospitalization where PCI was performed. The primary outcomes included death from any cause, stroke, transfusion, bleeding, and major bleeding. Post-PCI stroke was defined as a loss of neurological function caused by an ischemic or hemorrhagic event with residual symptoms lasting at least 24 hours after onset or leading to death. Transfusion was defined as transfusion of whole or packed red blood cells from the start of the procedure to the time of discharge. Bleeding was defined as any suspected or confirmed bleeding event within 72 hours of PCI that was associated with any of the following: (1) drop in serum hemoglobin of ≥3 g/dL, (2) transfusion of whole or packed red blood cells, or (3) procedural intervention/ surgery at the bleeding site to stop/reverse or correct the bleeding. 12 Major bleeding was defined as a drop in baseline hemoglobin of >5 g/dL. In an exploratory analysis, we also examined whether vascular access site used for PCI modified the association between a patient's history of TIA or stroke and post-PCI in-hospital stroke.
Postdischarge 90-Day Readmission and Long-Term Mortality
Among a subset of patients who could be linked to administrative Medicare claims, we performed a supplemental analysis to evaluate postdischarge outcomes among patients with and without a history of TIA or stroke. The Medicare data were made available through collaboration with the Michigan Value Collaborative. 13 The Michigan Value Collaborative constructs 90-day episodes of care using Medicare administrative claims. We linked our clinical registry data to PCI episodes through indirect matching of the index PCI procedure using multiple variables, including hospital and operator National Provider Identifier numbers; admission, discharge, and procedure dates for the index hospitalization; and patient sex and date of birth. 14, 15 After linking the data, we were able to determine postdischarge outcomes including 90-day readmission and long-term mortality (from any cause). Readmission was defined as admission to an acute care hospital for any reason within 90 days after discharge from the incident hospitalization or stay when PCI was performed. In addition, only the first readmission was counted per each PCI event. Postdischarge mortality, even beyond the 90-day episode, was obtained from the Medicare beneficiary file, which includes the date of death for deceased beneficiaries.
Statistical Analysis
Baseline characteristics were compared between patients with and without a history of TIA or stroke using Pearson χ 2 or Fisher exact test for categorical variables and Student t tests for continuous variables. For the analysis of in-hospital outcomes, propensity score matching and multivariable analysis were used to adjust for differences in baseline characteristics between those with and without a history of TIA or stroke. A list of the 31 clinical characteristics can be found in Table I in the Data Supplement. We required exact matching on coronary artery disease presentation, such as non-ST-segmentelevation MI and ST-segment-elevation MI. Patients with a history of TIA or stroke were matched in a 1:1 manner to patients without a history of TIA or stroke using a greedy matching algorithm. 16 Postdischarge outcomes were analyzed using the unmatched linked data set consisting of clinical and claims-based variables. We used a backward and forward stepwise selection routine with Akaike information criterion to select predictors included in final logistic regression and Cox proportional hazards models used to evaluate the outcomes of 90-day readmission and long-term mortality, respectively. 17 The variables included in the logistic regression and Cox proportional hazards models are listed in Tables II and III in the Data Supplement, respectively. Kaplan-Meier curves were used to display differences in cumulative mortality between the 2 groups of patients. A P value <0.05 was considered to be statistically significant. All analyses were performed using R, version 3.2.1.
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Results
Patient Characteristics
Between January 2013 and March 2016, a total of 98 730 consecutive patients underwent PCI at 47 hospitals in Michigan.
WHAT IS KNOWN
• Patients with a history of transient ischemic attack or stroke are at greater risk of developing coronary artery disease that may require percutaneous coronary intervention.
WHAT THE STUDY ADDS
• Using data from a large, multicenter clinical registry, we found that a history of transient ischemic attack or stroke is common (11.1%) among patients who underwent percutaneous coronary intervention.
• In addition, a history of transient ischemic attack or stroke was associated with a higher risk of postprocedure stroke, 90-day readmission, and long-term mortality compared with patients without a history of transient ischemic attack or stroke.
• Such patients should be appropriately counseled on these risks before percutaneous coronary intervention. Of these, 10 915 (11.1%) had a history of TIA or stroke before PCI. Before matching, patients with a history of TIA or stroke were more likely to be older, women, and have more cardiovascular comorbidities (Table) .
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In-Hospital Outcomes
Patients with a history of TIA or stroke had significantly higher rates of post-PCI adverse outcomes, including death (2.4% versus 1.5%; P<0.001), stroke (0.8% versus 0.3%; P<0.001), blood transfusion (4.3% versus 2.3%; P<0.001), and bleeding (4.3% versus 3.3%; P<0.001; Figure 1 ). However, there was no significant difference in the rate of major bleeding (1.0% versus 1.2%; P=0.184). After propensity score matching, 10 618 patients were included in each group. The absolute standardized differences were <10% on all matched variables, indicating acceptable covariate balance between the 2 groups (Figure 2 ). Among the matched cohort, patients with a history of TIA or stroke had a significantly higher risk of post-PCI stroke (adjusted odds ratio [ Figure 3) .
The association between a patient's history of TIA or stroke and post-PCI in-hospital stroke was not significantly modified by the vascular access site chosen for PCI. Among patients with a history of TIA or stroke, the rate of post-PCI in-hospital stroke was 0.93% and 0.77% for patients who underwent radial versus femoral PCI, respectively.
Postdischarge 90-Day Readmission and Long-Term Mortality
A total of 14 061 patients who underwent PCI in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium PCI registry were linked to administrative Medicare claims. The baseline characteristics of these patients can be found in Table IV in the Data Supplement. Among this subgroup of patients, 1933 (13.6%) had a history of TIA or stroke. Patients with a history of TIA or stroke had an increased risk of 90-day all-cause readmission (aOR, 1.22; 95% CI, 1.09-1.38; P<0.001) and an increased hazard of mortality (hazard ratio, 1.23; 95% CI, 1.07-1.43; P=0.005) compared with patients without a history of TIA or stroke. The unadjusted survival curves for patients with and without a history of TIA or stroke are shown in Figure 4 .
Discussion
There are 2 primary findings from our study. First, a history of TIA or stroke was common among patients who underwent All percentages represent frequencies. Where nominal values are used, they are presented as mean±SD. CABG indicates coronary artery bypass grafting; CAD, coronary artery disease; IABP, intra-aortic balloon pump; MI, myocardial infarction; NCDR, National Cardiovascular Data Registry; PCI, percutaneous coronary intervention; RBC, red blood cell; STEMI, ST-segment-elevation myocardial infarction; and TIA, transient ischemic attack. PCI and was associated with a 2-fold increased risk of post-PCI in-hospital stroke without significant differences in the risks of in-hospital bleeding, transfusion, or death. Second, among the subset of patients who could be linked to Medicare claims data, patients with a history of TIA or stroke experienced an increased risk of 90-day readmission and long-term mortality after PCI compared with patients without a history of TIA or stroke. Plot of absolute standardized differences before and after matching. Absolute standardized differences before and after matching patients with and without a history of transient ischemic attack or stroke. CABG indicates coronary artery bypass grafting; CAD, coronary artery disease; Hx, history; MI, myocardial infarction; PCI, percutaneous coronary intervention; STEMI, ST-segment-elevation myocardial infarction; and Sx, symptoms.
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The absolute incidence of post-PCI stroke in our study was low (0.36%), similar to findings from prior research with incidences ranging between 0.23% and 0.43%. 2, 9, 19, 20 However, patients with a history of TIA or stroke had a 2-fold increased risk of post-PCI stroke. Prior studies have evaluated the relationship between a history of TIA or stroke and post-PCI stroke and arrived at conflicting conclusions. For instance, similar to the findings from our study, Upadhya et al 9 and Li et al 21 demonstrated that patients with a history of TIA or stroke have an increased risk of post-PCI stroke, whereas Zhang et al 7 and Sasao et al 8 found no significant differences in the rates of post-PCI stroke in patients with and without a history of TIA or stroke. Our findings underscore the importance of appropriately counseling patients with a history of TIA or stroke on the risks of post-PCI in-hospital stroke. An open conversation of patient-specific risks and benefits of PCI is integral to the process of shared decision-making. At a minimum, patients with a history of TIA or stroke undergoing diagnostic coronary angiography with possible ad hoc PCI should routinely be informed of their increased risk of postprocedural in-hospital stroke.
We also found that patients with a history of TIA or stroke had a higher risk of 90-day readmission and long-term mortality. This may be related to the fact that atherosclerotic disease is present in at least 2 critical arterial beds in these patients, thus increasing the vulnerability of these patients to devastating or fatal events. 22, 23 Similar to our findings, Li et al 21 found that patients with a history of TIA or stroke had an increased risk of long-term mortality after PCI. However, their study did not evaluate the relationship with readmission-a costly event associated with adverse patient outcomes. 24 Moreover, in the current era of healthcare payment reform including the implementation of bundled payment models, effectively identifying patients with an increased risk of readmission, and preventing these costly events will be increasingly important. [25] [26] [27] More broadly, given the signals of harm seen in this population in 2 contemporary randomized controlled trials of antithrombotic therapies, 3, 4 the increased risk of postdischarge adverse outcomes may be related to the challenges of long-term antithrombotic therapy in this population. The mechanisms responsible for the increased risk of postdischarge complications in these patients remain unclear, highlighting the need for further research in this prevalent, high-risk population.
Study Limitations
Our study has several important limitations. First, although we attempted to account for differences in baseline characteristics among patients with and without a history of TIA or stroke through propensity score matching, we were unable to account for all potential confounders given the observational nature of the study. Second, all hospitals participating in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium PCI clinical registry are engaged in statewide collaborative quality improvement initiatives. Therefore, our findings may not be generalizable to hospitals in other states that do not participate in such initiatives. 28 Finally, among patients with a history of TIA or stroke, it may have been difficult to differentiate whether post-PCI stroke symptoms were because of new cerebrovascular events or whether they were because of poststroke recrudescence of symptoms. Recrudescence of stroke symptoms may be caused by sedating medications frequently used during PCI. 29 This may have led to an overestimation of the incidence of post-PCI stroke in the subgroup of patients with a history of TIA or stroke. However, our definition of post-PCI stroke required symptoms to be present for at least 24 hours, whereas among patients with symptoms because of poststroke recrudescence, the majority have resolution of symptoms within 24 hours. 29 
Conclusions
In this retrospective observational analysis of patients who underwent PCI, a history of TIA or stroke before PCI was common and associated with a 2-fold increased risk of post-PCI in-hospital stroke without significant differences in the risks of in-hospital bleeding, transfusion, or death. Our study provides important real-world evidence that a history of TIA or stroke is associated with adverse outcomes after PCI. Although the absolute increase in the risk of post-PCI stroke is small and may not dissuade practitioners from recommending PCI, given the possibly devastating consequences of post-PCI stroke, we think that patients with a history of TIA or stroke should be counseled on this increased risk in the current era of shared decision-making. In addition, further research is needed to understand the mechanisms responsible for the increased risks of post-PCI stroke and postdischarge adverse outcomes in this high-risk subgroup of patients so that effective strategies can be developed to reduce these risks.
